STAR Protocols (Sep 2024)

Protocol for producing hyperpolarized 13C-bicarbonate for clinical MRI of extracellular pH in aggressive tumors

  • Changhua Mu,
  • Xiaoxi Liu,
  • Andrew Riselli,
  • James Slater,
  • Evelyn Escobar,
  • Duy Dang,
  • Scott Drapeau,
  • Romelyn Delos Santos,
  • Stacy Andosca,
  • Hao Nguyen,
  • Peder E.Z. Larson,
  • Robert Bok,
  • Daniel B. Vigneron,
  • John Kurhanewicz,
  • David M. Wilson,
  • Robert R. Flavell

Journal volume & issue
Vol. 5, no. 3
p. 103091

Abstract

Read online

Summary: Tumor acidosis is one of the hallmarks indicating the initiation and progression of various cancers. Here, we present a protocol for preparing a hyperpolarized (HP) 13C-bicarbonate tissue pH MRI imaging contrast agent to detect aggressive tumors. We describe the steps for the formulation and polarization of a precursor molecule 13C-glycerol carbonate (13C-GLC), the post-dissolution reaction, and converting HP 13C-GLC to an injectable HP 13C-bicarbonate solution. We then detail procedures for MRI data acquisition to generate tumor pH maps for assessing tumor aggressiveness.For complete details on the use and execution of this protocol, please refer to Mu et al.1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Keywords